nach oben

International Urology and Nephrology

Erschienen in:

26.02.2018 | Nephrology - Original Paper

A1AR-mediated renal protection against ischemia/reperfusion injury is dependent on HSP27 induction

verfasst von: Bin Xiong, Min Li, Shulin Xiang, Lin Han

Erschienen in: International Urology and Nephrology | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A1 adenosine receptor (AR) activation has been demonstrated to attenuate renal ischemia/reperfusion injury (IRI), but the exact mechanism of this protection remains to be well elucidated.

Methods

Male C57BL/6 mice were used in the present study. Expression of heat shock protein (HSP) 27 and HSF-1 were detected using western blot analysis. An RNA interference with adenovirus vector using short hairpin RNA targeting HSP27 was developed. Together with renal IRI model, indicators of renal function, acute tubular necrosis, inflammation and apoptosis were measured in kidneys after 24-h reperfusion.

Results

We found activation of A1AR stimulated induction of HSP27 and its major transcriptional factor HSF-1. It was observed that renal inhibition of HSP27 abolished the renoprotective effects afforded by A1AR activation indicated by worse renal function, severer acute tubular necrosis and pro-inflammatory reaction. In addition, HSP27 induction by A1AR activation protects the kidney from IRI via suppressing cell apoptosis, proved by decreased caspase-3 activation and DNA fragmentation, which was also removed by inhibition of HSP27.

Conclusions

Activation of A1AR produces renoprotective effects via HSP27 induction. It suggests that preconditional HSP27 activation might have a great potential for the treatment of renal IRI.

Safian RD, Textor SC (2001) Renal-artery stenosis. N Engl J Med 344(6):431–442. https://doi.org/10.1056/NEJM200102083440607 CrossRefPubMed

Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351(2):159–169. https://doi.org/10.1056/NEJMra032401351/2/159 CrossRefPubMed

Kelly KJ, Molitoris BA (2000) Acute renal failure in the new millennium: time to consider combination therapy. Semin Nephrol 20(1):4–19PubMed

Sheridan AM, Bonventre JV (2001) Pathophysiology of ischemic acute renal failure. Contrib Nephrol 132:7–21CrossRef

Lafrance JP, Miller DR (2010) Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol 21(2):345–352. https://doi.org/10.1681/ASN.2009060636 CrossRefPubMedPubMedCentral

Lameire N, Van Biesen W, Vanholder R (2005) Acute renal failure. Lancet 365(9457):417–430. https://doi.org/10.1016/S0140-6736(05)17831-3 CrossRefPubMed

Joo JD, Kim M, Horst P, Kim J, D’Agati VD, Emala CW Sr, Lee HT (2007) Acute and delayed renal protection against renal ischemia and reperfusion injury with A1 adenosine receptors. Am J Physiol Renal Physiol 293(6):F1847–F1857. https://doi.org/10.1152/ajprenal.00336.2007 CrossRefPubMed

Lee HT, Gallos G, Nasr SH, Emala CW (2004) A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia–reperfusion injury in mice. J Am Soc Nephrol JASN 15(1):102–111CrossRefPubMed

Lee HT, Kim M, Jan M, Penn RB, Emala CW (2007) Renal tubule necrosis and apoptosis modulation by A1 adenosine receptor expression. Kidney Int 71(12):1249–1261. https://doi.org/10.1038/sj.ki.5002227 CrossRefPubMed

10.

Concannon CG, Gorman AM, Samali A (2003) On the role of Hsp27 in regulating apoptosis. Apoptosis Int J Program Cell Death 8(1):61–70CrossRef

11.

Kostenko S, Moens U (2009) Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci CMLS 66(20):3289–3307. https://doi.org/10.1007/s00018-009-0086-3 CrossRefPubMed

12.

Kim M, Park SW, Chen SW, Gerthoffer WT, D’Agati VD, Lee HT (2010) Selective renal overexpression of human heat shock protein 27 reduces renal ischemia–reperfusion injury in mice. Am J Physiol Renal Physiol 299(2):F347–F358. https://doi.org/10.1152/ajprenal.00194.2010 CrossRefPubMedPubMedCentral

13.

Zhang S, Han CH, Chen XS, Zhang M, Xu LM, Zhang JJ, Xia Q (2012) Transient ureteral obstruction prevents against kidney ischemia/reperfusion injury via hypoxia-inducible factor (HIF)-2α activation. PLoS ONE 7(1):e29876. https://doi.org/10.1371/journal.pone.0029876 CrossRefPubMedPubMedCentral

14.

Chatterjee PK, Thiemermann C (2003) An in vivo model of ischemia/reperfusion and inflammation of the kidneys of the rat. Methods Mol Biol 225:223–237. https://doi.org/10.1385/1-59259-374-7:223 PubMedCrossRef

15.

Chatterjee PK, Patel NS, Kvale EO, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Thiemermann C (2002) Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 61(3):862–871. https://doi.org/10.1046/j.1523-1755.2002.00234.x CrossRefPubMed

16.

Xiao X, Zuo X, Davis AA, McMillan DR, Curry BB, Richardson JA, Benjamin IJ (1999) HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice. EMBO J 18(21):5943–5952. https://doi.org/10.1093/emboj/18.21.5943 CrossRefPubMedPubMedCentral

17.

Donnahoo KK, Shames BD, Harken AH, Meldrum DR (1999) Review article: the role of tumor necrosis factor in renal ischemia–reperfusion injury. J Urol 162(1):196–203. https://doi.org/10.1097/00005392-199907000-00068 CrossRefPubMed

18.

Burne-Taney MJ, Kofler J, Yokota N, Weisfeldt M, Traystman RJ, Rabb H (2003) Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am J Physiol Renal Physiol 285(1):F87–F94. https://doi.org/10.1152/ajprenal.00026.2003 CrossRefPubMed

19.

Loverre A, Ditonno P, Crovace A, Gesualdo L, Ranieri E, Pontrelli P, Stallone G, Infante B, Schena A, Di Paolo S, Capobianco C, Ursi M, Palazzo S, Battaglia M, Selvaggi FP, Schena FP, Grandaliano G (2004) Ischemia–reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin. J Am Soc Nephrol JASN 15(10):2675–2686. https://doi.org/10.1097/01.ASN.0000139932.00971.E4 CrossRefPubMed

20.

Patel NS, Chatterjee PK, Di Paola R, Mazzon E, Britti D, De Sarro A, Cuzzocrea S, Thiemermann C (2005) Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exp Ther 312(3):1170–1178. https://doi.org/10.1124/jpet.104.078659 CrossRefPubMed

21.

Hirano S, Rees RS, Yancy SL, Welsh MJ, Remick DG, Yamada T, Hata J, Gilmont RR (2004) Endothelial barrier dysfunction caused by LPS correlates with phosphorylation of HSP27 in vivo. Cell Biol Toxicol 20(1):1–14CrossRefPubMed

22.

Howard TK, Klintmalm GB, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA (1990) The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 49(1):103–107CrossRefPubMed

23.

Hansen PB, Hashimoto S, Oppermann M, Huang Y, Briggs JP, Schnermann J (2005) Vasoconstrictor and vasodilator effects of adenosine in the mouse kidney due to preferential activation of A1 or A2 adenosine receptors. J Pharmacol Exp Ther 315(3):1150–1157. https://doi.org/10.1124/jpet.105.091017 CrossRefPubMed

24.

Vallon V, Muhlbauer B, Osswald H (2006) Adenosine and kidney function. Physiol Rev 86(3):901–940. https://doi.org/10.1152/physrev.00031.2005 CrossRefPubMed

25.

Yap SC, Lee HT (2012) Adenosine and protection from acute kidney injury. Curr Opin Nephrol Hypertens 21(1):24–32. https://doi.org/10.1097/MNH.0b013e32834d2ec9 CrossRefPubMedPubMedCentral

26.

Irazu CE, Ruidera E, Singh I, Orak JK, Fitts CT, Rajagopalan PR (1989) Effect of ischemia and 24 hour reperfusion on ATP synthesis in the rat kidney. J Exp Pathol 4(1):29–36PubMed

27.

Eltzschig HK, Thompson LF, Karhausen J, Cotta RJ, Ibla JC, Robson SC, Colgan SP (2004) Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 104(13):3986–3992. https://doi.org/10.1182/blood-2004-06-2066 CrossRefPubMed

28.

Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, Schonfeld C, Loffler M, Reyes G, Duszenko M, Karhausen J, Robinson A, Westerman KA, Coe IR, Colgan SP (2005) HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202(11):1493–1505. https://doi.org/10.1084/jem.20050177 CrossRefPubMedPubMedCentral

29.

Zhao ZQ, Nakanishi K, McGee DS, Tan P, Vinten-Johansen J (1994) A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia. Cardiovasc Res 28(2):270–279CrossRefPubMed

30.

Narayan P, Mentzer RM Jr, Lasley RD (2001) Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes. J Mol Cell Cardiol 33(1):121–129. https://doi.org/10.1006/jmcc.2000.1282 CrossRefPubMed

31.

Phillis JW (1995) The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil. Brain Res 705(1–2):79–84CrossRefPubMed

32.

Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, Solary E (1999) HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 13(14):2061–2070CrossRefPubMed

33.

Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, Diaz-Latoud C, Gurbuxani S, Arrigo AP, Kroemer G, Solary E, Garrido C (2000) Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2(9):645–652. https://doi.org/10.1038/35023595 CrossRefPubMed

34.

Arrigo AP, Firdaus WJ, Mellier G, Moulin M, Paul C, Diaz-latoud C, Kretz-remy C (2005) Cytotoxic effects induced by oxidative stress in cultured mammalian cells and protection provided by Hsp27 expression. Methods 35(2):126–138. https://doi.org/10.1016/j.ymeth.2004.08.003 CrossRefPubMed

35.

Park SW, Chen SW, Kim M, D’Agati VD, Lee HT (2009) Human heat shock protein 27-overexpressing mice are protected against acute kidney injury after hepatic ischemia and reperfusion. Am J Physiol Renal Physiol 297(4):F885–F894. https://doi.org/10.1152/ajprenal.00317.2009 CrossRefPubMedPubMedCentral

36.

Chen SW, Park SW, Kim M, Brown KM, D’Agati VD, Lee HT (2009) Human heat shock protein 27 overexpressing mice are protected against hepatic ischemia and reperfusion injury. Transplantation 87(10):1478–1487. https://doi.org/10.1097/TP.0b013e3181a3c691 CrossRefPubMedPubMedCentral

37.

Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR (1999) Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia–reperfusion. Am J Physiol 277(3 Pt 2):R922–R929PubMed

38.

Zager RA, Johnson AC, Becker K (2011) Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and “end-stage” kidney disease. Am J Physiol Renal Physiol 301(6):F1334–F1345. https://doi.org/10.1152/ajprenal.00431.2011 CrossRefPubMedPubMedCentral

39.

Amura CR, Renner B, Lyubchenko T, Faubel S, Simonian PL, Thurman JM (2012) Complement activation and toll-like receptor-2 signaling contribute to cytokine production after renal ischemia/reperfusion. Mol Immunol 52(3–4):249–257. https://doi.org/10.1016/j.molimm.2012.05.020 CrossRefPubMedPubMedCentral

40.

Heinzelmann M, Mercer-Jones MA, Passmore JC (1999) Neutrophils and renal failure. Am J Kidney Dis 34(2):384–399. https://doi.org/10.1053/AJKD03400384 CrossRefPubMed

41.

Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, Bonventre JV (1996) Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Investig 97(4):1056–1063. https://doi.org/10.1172/JCI118498 CrossRefPubMedPubMedCentral

42.

Ysebaert DK, De Greef KE, Vercauteren SR, Ghielli M, Verpooten GA, Eyskens EJ, De Broe ME (2000) Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 15(10):1562–1574CrossRefPubMed

43.

Daemen MA, de Vries B, Buurman WA (2002) Apoptosis and inflammation in renal reperfusion injury. Transplantation 73(11):1693–1700CrossRefPubMed

44.

Daemen MA, van’t Veer C, Denecker G, Heemskerk VH, Wolfs TG, Clauss M, Vandenabeele P, Buurman WA (1999) Inhibition of apoptosis induced by ischemia–reperfusion prevents inflammation. J Clin Investig 104(5):541–549. https://doi.org/10.1172/JCI6974 CrossRefPubMedPubMedCentral

45.

Ganachari N, Kaur P, Asea A (2012) Role of Human and Mouse HspB1 in Metastasis. Curr Mol Med 12(9):1142–1150CrossRef

Titel: A1AR-mediated renal protection against ischemia/reperfusion injury is dependent on HSP27 induction
verfasst von: Bin Xiong
Min Li
Shulin Xiang
Lin Han
Publikationsdatum: 26.02.2018
Verlag: Springer Netherlands
Erschienen in: International Urology and Nephrology / Ausgabe 7/2018
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-018-1797-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Chronisches Koronarsyndrom: Gefahr von Hospitalisierung wegen Herzinsuffizienz

06.05.2024 Herzinsuffizienz Nachrichten

Obwohl ein rezidivierender Herzinfarkt bei chronischem Koronarsyndrom wahrscheinlich die Hauptsorge sowohl der Patienten als auch der Ärzte ist, sind andere Ereignisse womöglich gefährlicher. Laut einer französischen Studie stellt eine Hospitalisation wegen Herzinsuffizienz eine größere Gefahr dar.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

GLP-1-Rezeptoragonisten und SGLT-2-Hemmer: zusammen besser

06.05.2024 Typ-2-Diabetes Nachrichten

Immer häufiger wird ein Typ-2-Diabetes sowohl mit einem GLP-1-Rezeptor-Agonisten als auch mit einem SGLT-2-Inhibitor behandelt. Wie sich das verglichen mit den Einzeltherapien auf kardiovaskuläre und renale Komplikationen auswirkt, wurde anhand von Praxisdaten aus Großbritannien untersucht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2018

How common is Balkan endemic nephropathy among immigrants in endemic regions?

The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease

Relationship between fatigue symptoms and subjective and objective indicators in hemodialysis patients

24-h urine metabolic profile: is it necessary in all kidney stone formers?

Principles of quantitative water and electrolyte replacement of losses from osmotic diuresis